Drug · DIN 02231592
DIFFERIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 8, 1998; first marketed January 8, 1998.
- Drug Identification Number (DIN)
- 02231592
- Company (DIN owner)
- Galderma Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Topical
- Therapeutic class (ATC)
- Adapalene D10AD03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADAPALENE | 0.1 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 24, 1997: NOC 3262Supplement to a New Drug Submission (SNDS) · Provides for a new dosage form: cream
Other DINs named DIFFERIN
- DIN 02148749 · Marketed
- DIN 02148757 · Cancelled Post Market
- DIN 02376660 · Approved